This framework provides a template to de-risk and improve the process."vLetter from the Association of the British Pharmaceutical Industry on Supply and Demand for Medicines following 21 January 2020 meeting, 26 February 2020
We were told of circumstances in which medicines were being used for indications for which they were not licensed and Lindsay McClure, Associate Director, Medicines Pricing and Supply, NHS National Services Scotland, spokeiiHealth and Sport Committee, Official Report, 21 January 2020, Col 60 of legal challenges in this regard.